Literature DB >> 21401380

Home-use TriPollar RF device for facial skin tightening: Clinical study results.

Ghislaine Beilin1.   

Abstract

BACKGROUND: Professional, non-invasive, anti-aging treatments based on radio-frequency (RF) technologies are popular for skin tightening and improvement of wrinkles. A new home-use RF device for facial treatments has recently been developed based on TriPollar™ technology.
OBJECTIVE: To evaluate the STOP™ home-use device for facial skin tightening using objective and subjective methods.
METHODS: Twenty-three female subjects used the STOP at home for a period of 6 weeks followed by a maintenance period of 6 weeks. Facial skin characteristics were objectively evaluated at baseline and at the end of the treatment and maintenance periods using a three-dimensional imaging system. Additionally, facial wrinkles were classified and subjects scored their satisfaction and sensations.
RESULTS: Following STOP treatment, a statistically significant reduction of perioral and periorbital wrinkles was achieved in 90% and 95% of the patients, respectively, with an average periorbital wrinkle reduction of 41%. This objective result correlated well with the periorbital wrinkle classification result of 40%. All patients were satisfied to extremely satisfied with the treatments and all reported moderate to excellent visible results.
CONCLUSIONS: The clinical study demonstrated the safety and efficacy of the STOP home-use device for facial skin tightening. Treatment can maintain a tighter and suppler skin with improvement of fine lines and wrinkles.

Entities:  

Mesh:

Year:  2011        PMID: 21401380     DOI: 10.3109/14764172.2011.552607

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  1 in total

1.  Home-based devices in dermatology: a systematic review of safety and efficacy.

Authors:  Marc Cohen; Evan Austin; Natasha Masub; Alana Kurtti; Christopher George; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2021-05-03       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.